New York S 4374: Directs that the department of health include information regarding the administration of overdose reversal agents on the prescription monitoring program registry

Status: REFERRED TO HEALTH (as of 2018-01-03)

State: New York · Session: 2017-2018 · Bill: S 4374

Sponsors: AMEDORE

View New York S 4374 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.